{
    "clinical_study": {
        "@rank": "60388", 
        "acronym": "FOCUS", 
        "arm_group": [
            {
                "arm_group_label": "FMT infusions", 
                "arm_group_type": "Active Comparator", 
                "description": "FMT infusions constituted from stool provided by healthy, screened donors"
            }, 
            {
                "arm_group_label": "Placebo arm", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Placebo infusions"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to determine whether fecal microbiota transplantation (FMT) is\n      safe and efficacious in the treatment and induction of remission of chronic active\n      ulcerative colitis (UC) by conducting a randomised controlled trial"
        }, 
        "brief_title": "Faecal Microbiota Transplantation in Ulcerative Colitis", 
        "completion_date": {
            "#text": "September 2016", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Ulcerative Colitis", 
            "Inflammatory Bowel Disease"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Colitis", 
                "Colitis, Ulcerative", 
                "Inflammatory Bowel Diseases", 
                "Intestinal Diseases", 
                "Ulcer"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Ulcerative colitis >3 months duration\n\n          -  Active mild-moderate ulcerative colitis (Mayo 4-10)\n\n          -  Ulcerative colitis of any extent except isolated proctitis < 5cm\n\n          -  Live within driving distance of clinical site (to attend multiple study visits)\n\n        Exclusion Criteria:\n\n          -  Pregnancy\n\n          -  Active gastrointestinal infection\n\n          -  Other gastrointestinal disease / comorbidities\n\n          -  Prior colonic surgery\n\n          -  Recent antibiotic or probiotic use\n\n          -  Prednisone > 20mg\n\n          -  Monoclonal antibody immunosuppressive therapy"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "75 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "80", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "July 6, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01896635", 
            "org_study_id": "FOCUS"
        }, 
        "intervention": [
            {
                "arm_group_label": "FMT infusions", 
                "intervention_name": "FMT infusions", 
                "intervention_type": "Biological"
            }, 
            {
                "arm_group_label": "Placebo arm", 
                "intervention_name": "Placebo infusion", 
                "intervention_type": "Other"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "Ulcerative Colitis", 
            "Inflammatory Bowel Disease", 
            "Fecal Transplantation", 
            "Fecal Microbiota Transplantation"
        ], 
        "lastchanged_date": "March 23, 2014", 
        "location": [
            {
                "contact": {
                    "last_name": "Alissa Walsh, MBBS (Hons) FRACP"
                }, 
                "facility": {
                    "address": {
                        "city": "Sydney", 
                        "country": "Australia", 
                        "state": "New South Wales", 
                        "zip": "2010"
                    }, 
                    "name": "St Vincent's Hospital"
                }, 
                "investigator": {
                    "last_name": "Alissa Walsh, MBBS (Hons) FRACP", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Douglas Samuel, BSc(Med) MBBS(Hons) MMed FRACP"
                }, 
                "facility": {
                    "address": {
                        "city": "Sydney", 
                        "country": "Australia", 
                        "state": "New South Wales", 
                        "zip": "2200"
                    }, 
                    "name": "Bankstown-Lidcombe Hospital"
                }, 
                "investigator": {
                    "last_name": "Douglas Samuel, BSc(Med) MBBS(Hons) MMed FRACP", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Johan van den Bogaerde, MBChB, MMed, PhD, MRCP, FRACP"
                }, 
                "facility": {
                    "address": {
                        "city": "Nambour", 
                        "country": "Australia", 
                        "state": "Queensland", 
                        "zip": "4560"
                    }, 
                    "name": "Nambour General Hospital"
                }, 
                "investigator": {
                    "last_name": "Johan van den Bogaerde, MBChB, MMed, PhD, MRCP, FRACP", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "Australia"
        }, 
        "number_of_arms": "2", 
        "official_title": "Faecal Microbiota Transplantation for Chronic Active Ulcerative Colitis - A Randomised Double Blind Controlled Study of Efficacy & Safety", 
        "overall_contact": {
            "email": "sparam_au@yahoo.com", 
            "last_name": "Sudarshan Paramsothy, BSc(Med)MBBS MRCP FRACP", 
            "phone": "(61 2) 8382 2061"
        }, 
        "overall_official": [
            {
                "affiliation": "University of New South Wales", 
                "last_name": "Hazel Mitchell, BSc(Hons), Dip Ed, PhD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "St Vincent's Hospital, Sydney", 
                "last_name": "Alissa Walsh, MBBS (Hons) FRACP", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Nambour General Hospital, Queensland", 
                "last_name": "Johan van den Bogaerde, MBChB PhD FCP MMed FRACP", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Bankstown-Lidcombe Hospital, Sydney", 
                "last_name": "Douglas Samuel, BSc(Med) MBBS(Hons) MMed FRACP", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "University of New South Wales", 
                "last_name": "Nadeem O Kaakoush, BSc(Hons), PhD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "University of Melbourne", 
                "last_name": "Michael Kamm, MBBS, MD, FRCP, FRACP", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": [
                "Australia: Department of Health and Ageing Therapeutic Goods Administration", 
                "Australia: Human Research Ethics Committee"
            ]
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "December 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Clinical remission as measured by Mayo subscores", 
            "safety_issue": "No", 
            "time_frame": "8 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01896635"
        }, 
        "responsible_party": {
            "investigator_affiliation": "The University of New South Wales", 
            "investigator_full_name": "Dr. Sudarshan Paramsothy", 
            "investigator_title": "Gastroenterologist / PhD candidate", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "measure": "Clinical and Endoscopic remission as measured by Mayo subscores and UCEIS", 
                "safety_issue": "No", 
                "time_frame": "8 weeks"
            }, 
            {
                "measure": "Clinical response as measured by Mayo subscores", 
                "safety_issue": "No", 
                "time_frame": "8 weeks"
            }, 
            {
                "measure": "Endoscopic healing as measured by UCEIS", 
                "safety_issue": "No", 
                "time_frame": "8 weeks"
            }, 
            {
                "measure": "Treatment failure rate as defined by Mayo subscores", 
                "safety_issue": "No", 
                "time_frame": "8 weeks"
            }, 
            {
                "measure": "Quality of life as measured by IBDQ", 
                "safety_issue": "No", 
                "time_frame": "8 weeks"
            }, 
            {
                "measure": "Safety and tolerability as measured by adverse event data", 
                "safety_issue": "Yes", 
                "time_frame": "8 weeks"
            }
        ], 
        "source": "The University of New South Wales", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "The University of New South Wales", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "November 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "March 2014"
    }
}